ARTICLE | Company News
QLT receives new Visudyne indication
August 23, 2001 7:00 AM UTC
QLT (TSE:QLT; QLTI) and partner Novartis Ophthalmics (Bulach, Switzerland) received FDA approval for Visudyne verteporfin injection to treat predominantly classic subfoveal choroidal neovascularizatio...